The first batch of data from Pfizer’s post marketing pharmacovigilance report began being released on Nov 17, 2021 of what will ultimately be 329,000 pages.
The information was ordered by a court to provide to satisfy a Freedom of Information request by a group called Public Health and Medical Professionals for Transparency who want to access the data used by the FDA to approve Pfiz...
To access content, please login or purchase a subscription.